Myeloma Data at ASH 2016 Focus on Novel Combinations
The presentations at ASH 2016 for multiple myeloma focused on novel drug combinations in various settings, including newly diagnosed myeloma and refractory disease.
Myeloma Data at ASH 2016 Focus on Novel Combinations
The presentations at ASH 2016 for multiple myeloma focused on novel drug combinations in various settings, including newly diagnosed myeloma and refractory disease.